Benzinga's Top #PreMarket Losers

by Monica Gerson, Benzinga Staff Writer

December 19, 2014 9:33 AM | 25 seconds read | Make a Comment

ImmunoGen, Inc.IMGN

shares dropped 45.30% to $5.94 after the company reported that Roche has provided an update on the MARIANNE trial.

Finish Line Inc.FINL

shares fell 12.80% to $25.20 on downbeat quarterly results.

BlackBerry LimitedBBRY

slipped 8.24% to $9.24 in pre-market trading after the company reported Q3 results.

Bellicum Pharmaceuticals, IncBLCM

declined 3.69% to $23 in pre-market trading.

Posted In: News Movers & Shakers Pre-Market Outlook Markets Top Losers

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.